Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Balance Targeted Exercises for Individuals With MS [NA]
Clinical trial update on a completed study evaluating balance-targeted exercises for individuals with multiple sclerosis. The trial was cond…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Visual (Path)Ways in Multiple Sclerosis - Part II [NA]
Recruitment is ongoing for Visual (Path)Ways in Multiple Sclerosis - Part II, a study enrolling participants with multiple sclerosis, optic …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Effectiveness of a Digital Health Application for Multiple Sclerosis (Levidex) [NA]
A completed clinical trial evaluated the effectiveness of Levidex, a digital health application, in people with multiple sclerosis.
-
FDA approval · 2025-01-29FDA Approved: TERIFLUNOMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals’ supplemental application to authorize a generic teriflunomide product for use in treating multiple …
-
FDA approval · 2025-01-28FDA Approved: TASCENSO ODT — Supplemental Application (Cycle Pharmaceuticals Ltd)
FDA approved a supplemental application to add TASCENSO ODT (fingolimod lauryl sulfate) as an orally disintegrating tablet form, expanding f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Relıabılıty and valıdıty of the supıne-to-stand Test wıth Multiple Sclerosis
A completed clinical trial evaluating the reliability and validity of the supine-to-stand test in individuals with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Telehealth Pain Self-Management for Employed Adults [NA]
This report notes the completion of a trial evaluating telehealth pain self-management for employed adults with chronic pain and related neu…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 [Phase 1]
First-in-human Phase 1 trial in healthy adults to evaluate safety, tolerability, and pharmacokinetics of LPX-TI641; the study has completed.
-
FDA approval · 2025-01-22FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for COPAXONE (glatiramer acetate) by Teva Neuroscience, Inc. The document indicates approval of a su…
-
FDA approval · 2025-01-22FDA Approved: FINGOLIMOD — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Fingolimod from Aurobindo Pharma Limited, approving a generic fingolimod product. The approval c…
-
FDA approval · 2025-01-22FDA Approved: FINGOLIMOD — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Fingolimod filed by Dr. Reddy's Laboratories, indicating regulatory approval for a change relate…
-
FDA approval · 2025-01-22FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals' supplemental application for dimethyl fumarate (generic version) under ANDA210309. This marks regulat…
-
FDA approval · 2025-01-22FDA Approved: FINGOLIMOD — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for fingolimod submitted by Glenmark Pharmaceuticals Inc., USA, updating the existing approval f…
-
FDA approval · 2025-01-22FDA Approved: FINGOLIMOD — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for fingolimod by Apotex Corp., enabling the manufacture and distribution of a generic fingolimod pr…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy [Phase 3]
A Phase 3 safety study evaluating immune responses to vaccines in relapsing forms of multiple sclerosis in participants receiving ozanimod v…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating natalizumab for preventing postpartum relapses in multiple sclerosis has completed. Results were posted on 2025-01-…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension) [Phase 4]
This update reports an extension of the MAGNIFY MS trial for Mavenclad in multiple sclerosis, with Phase 4 results posted in January 2025.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: The Gilenya Pregnancy Registry
A completed observational pregnancy registry evaluating outcomes in patients exposed to fingolimod (Gilenya) for multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Psilocybin Therapy for Psychological Distress in Palliative Patients [Phase 2]
Phase 2 trial update on psilocybin therapy for psychological distress in palliative patients; status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Effect of Cladribine Treatment on Microglial Activation in the CNS
A clinical trial assesses whether cladribine treatment affects microglial activation in the central nervous system in multiple sclerosis, wi…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis. [Phase 4]
Phase 4 trial evaluating the efficacy and response to ozanimod in multiple sclerosis has been terminated, per the clinical trial update.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Multimodal Imaging of MS Reveals the Smoldering Inflammation
Clinical trial update on multimodal imaging of multiple sclerosis, focusing on smoldering inflammation; the study is currently active but no…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Stem Cells in Rapidly Evolving Active Multiple Sclerosis [Phase 1, Phase 2]
Clinical trial update for a stem cell therapy in rapidly evolving active multiple sclerosis. The Phase 1/Phase 2 study has completed and res…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Kesimpta (Ofatumumab) Pregnancy Registry
This clinical trial update describes a Kesimpta (ofatumumab) pregnancy registry that is currently recruiting to collect safety data on pregn…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis [Phase 2]
This is a Phase 2 clinical trial update for KYSA-7, an anti-CD19 CAR T-cell therapy from Kyverna Therapeutics, studied in adults with refrac…